MENU
+Compare
ATRC
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$35.45
Change
+$0.05 (+0.14%)
Capitalization
1.76B

ATRC AtriCure Forecast, Technical & Fundamental Analysis

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors... Show more

ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ATRC with price predictions
Aug 15, 2025

Momentum Indicator for ATRC turns positive, indicating new upward trend

ATRC saw its Momentum Indicator move above the 0 level on July 25, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 71 similar instances where the indicator turned positive. In of the 71 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ATRC just turned positive on July 25, 2025. Looking at past instances where ATRC's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

ATRC moved above its 50-day moving average on July 30, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ATRC crossed bullishly above the 50-day moving average on August 04, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRC advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ATRC moved out of overbought territory on August 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 64 cases where ATRC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ATRC broke above its upper Bollinger Band on July 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ATRC entered a downward trend on July 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.794) is normal, around the industry mean (10.930). P/E Ratio (0.000) is within average values for comparable stocks, (62.278). ATRC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.881). ATRC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.357) is also within normal values, averaging (39.773).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATRC is expected to report earnings to fall 12.54% to -11 cents per share on October 29

AtriCure ATRC Stock Earnings Reports
Q3'25
Est.
$-0.11
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.02
The last earnings report on July 29 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 329.39K shares outstanding, the current market capitalization sits at 1.76B.
A.I. Advisor
published General Information

General Information

a manufacturer of surgical and medical instruments

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
7555 Innovation Way
Phone
+1 513 755-4100
Employees
1200
Web
https://www.atricure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEQUX17.910.07
+0.39%
Putnam Focused International Equity A
PGDRX11.850.02
+0.17%
Principal Diversified Real Asset R3
LCMIX47.320.07
+0.15%
ClearBridge Mid Cap Growth IS
FCPIX38.020.02
+0.05%
Fidelity Advisor Intl Cap App I
VICCX22.45-0.06
-0.27%
USA Mutuals Vice C

ATRC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with SIBN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then SIBN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
+0.11%
SIBN - ATRC
44%
Loosely correlated
+1.05%
IRMD - ATRC
42%
Loosely correlated
+0.33%
NVST - ATRC
38%
Loosely correlated
-0.86%
TMCI - ATRC
37%
Loosely correlated
-0.86%
CERS - ATRC
37%
Loosely correlated
-2.36%
More

Groups containing ATRC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
+0.11%
Pharmaceuticals: Other
industry (105 stocks)
28%
Poorly correlated
-0.56%
Pharmaceuticals
industry (394 stocks)
24%
Poorly correlated
-1.04%